Targeting TRAF6/IRF3 axis to inhibit NF-κB-p65 nuclear translocation enhances the chemosensitivity of 5-FU and reverses the proliferation of gastric cancer
Abstract Chemoresistance poses a significant clinical challenge in the treatment of gastric cancer (GC), while its underlying molecular mechanisms are still not fully understood. Post-translational protein modification and abnormal activation of nuclear factor-kappa B (NF-κB) are critical regulators...
Saved in:
| Main Authors: | Shitong Chen, Dong Zhang, Yi Du, Junbo Shi, Sikuan Gu, Xujun Zhou, Huijuan Yu, Feng Wang, Jinfei Chen, Hongjuan Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-12-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-024-07290-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GRK2 activates TRAF2–NF-κB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis
by: Chenchen Han, et al.
Published: (2025-04-01) -
Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis
by: Yuhua Ma, et al.
Published: (2024-12-01) -
Epidermal p65/NF‐κB signalling is essential for skin carcinogenesis
by: Chun Kim, et al.
Published: (2014-06-01) -
Targeting DKC1/NF-κB axis suppresses tumorigenesis and enhances 5-FU sensitivity in gastric cancer
by: Tengkai wang, et al.
Published: (2025-07-01) -
Artesunate Promotes Bone Remodeling Through TRAF6-Mediated NF-κB Signaling Under Orthodontic Stress in Diabetic Rats
by: Yuxiang Zhan, et al.
Published: (2025-08-01)